CLINICAL PHARMACOKINETIC CHARACTERISTICS AND THE EFFECT OF FOOD ON RADOTINIB IN HEALTHY VOLUNTEERS

EHA Library, Yerin Lee, 4161801

USE OF RUXOLITINIB AS SECOND-LINE TREATMENT IN PATIENTS WITH POLYCYTHAEMIA VERA: A MULTICENTRE STUDY.

EHA Library, Laura Curras Sanchez, 4162185

PLATELET COUNT OVER TIME IS NOT ASSOCIATED WITH INCIDENCE OF THROMBOSIS IN ASIAN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA

EHA Library, Yoshimasa Kamoda, 4162186

EVALUATING INTERVENTIONAL TRIALS IN MYELOFIBROSIS-ASSOCIATED ANEMIA: A SYSTEMATIC LITERATURE REVIEW OF BASELINE ANEMIA STATUS AND TRANSFUSION INDEPENDENCE OUTCOMES

EHA Library, Haifa Kathrin Al-Ali, 4162187

ANALYSIS OF THROMBOSIS EVENTS AND OUTCOMES BETWEEN JAK2 CHIP AND MPN PATIENTS: UK-BASED EXPERIENCE

EHA Library, Connor MacMillan, 4162188

TRIAL-IN-PROGRESS: A PHASE 2 STUDY OF RUXOLITINIB IN LOW-RISK ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA PATIENTS WITH HIGH SYMPTOM BURDEN

EHA Library, Joan How, 4162189

IMPACT OF DNMT3A MUTATION ON TREATMENT RESPONSE TO ROPEGINTERFERON ALPHA-2B IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA

EHA Library, Tsewang Tashi, 4162190

PRIMARY MYELOFIBROSIS AND THROMBOTIC RISK: LOWER-RISK IPSS VS HIGHER-RISK IPSS

EHA Library, Veronica Vecchio, 4162191

SINGLE-CENTER DIAGNOSTIC FINDINGS OF SYSTEMIC MASTOCYTOSIS

EHA Library, Zarema Abdulkhalikova, 4162193

ASSOCIATION BETWEEN CHEMOTHERAPY FOR NONMETASTATIC BREAST CANCER AND RISK OF SECONDARY HEMATOLOGIC MALIGNANCIES

EHA Library, WenJing Lang, 4162194

A MULTICENTER, OPEN-LABEL PHASE 1 STUDY OF INCB160058, A FIRST-IN-CLASS JAK2 V617F MUTANT-SPECIFIC INHIBITOR, IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS (MPN)

EHA Library, Jason Gotlib, 4162195

SUCCESS OF INTERACTIVE CASE-BASED ONLINE EDUCATION TO ENHANCE HEMATOLOGIST/ONCOLOGISTS' MYELOFIBROSIS MANAGEMENT SKILLS

EHA Library, Sarah Elizabeth Bomba, 4162196

THE EFFECT OF THE DIFFERENT THERAPY ON FUNCTIONAL ACTIVITY OF PLASMA MICROPARTICLES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA

EHA Library, Olga Golovina, 4162197

DECODING MYELOFIBROSIS: THE ROLE OF CYTOGENETICS IN DIAGNOSIS AND PROGNOSIS

EHA Library, Christos Varelas, 4162198

THE USE OF ACE INHIBITORS DOES NOT HAVE AN IMPACT ON DISEASE SYMPTOMS IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Hrvoje Holik, 4162199

JAK2 V617F/C618R MUTATION - A CHALLENGE IN DIAGNOSIS OF POLYCYTHEMIA VERA

EHA Library, Pedro Pinho Moura, 4162200

EVALUATION OF THE REVISED IPSET SCORE IN PREDICTING THROMBOTIC RISK AND GUIDING MANAGEMENT IN ESSENTIAL THROMBOCYTHEMIA

EHA Library, Ines Ben Rekaya, 4162201

MORE THAN 15 YEARS OF MASTOCYTOSIS EXPERIENCE IN A SINGLE CENTER ACCORDING TO CURRENT GUIDELINES

EHA Library, Merve Aydoğan, 4162202

CURRENT STATUS OF DIAGNOSIS AND TREATMENT FOR MYELOPROLIFERATIVE NEOPLASMS IN CHINA AND OBSERVATIONS ON CLINICIANS' PRACTICE PATTERNS

EHA Library, Bing Li, 4162203

THE EFFECT OF ALTITUDE ON POLYCYTHEMIA VERA: IS IT NECESSARY TO CHANGE LIMITS? SHORT TITLE: THE EFFECT OF ALTITUDE ON POLYCYTHEMIA

EHA Library, Edibe Sevde EKER, 4162204

REAL LIFE DATA OF YOUNG PRIMARY MYELOFIBROSIS PATIENTS IN AZERBAIJAN

EHA Library, Elmir Guluyev, 4162205

CENTRAL RETINAL VEIN OCCLUSION AS THE ONSET OF CMPN

EHA Library, Lidiya Egoryan, 4162206

POLYCYTHEMIA VERA: EPIDEMIOLOGICAL, DIAGNOSTIC, AND THERAPEUTIC INSIGHTS FROM A 16-YEAR STUDY

EHA Library, Aya Zaouali Dridi, 4162207

PRIMARY MYELOFIBROSIS: A SINGLE CENTER EXPERIENCE IN TUNISIA

EHA Library, Imen Ben Amor, 4162208

CLINICAL AND MOLECULAR CHARACTERISTICS OF ESSENTIAL THROMBOCYTHEMIA IN A MEXICAN COHORT

EHA Library, Liliana Regalado, 4162209

OUTCOMES OF MYELOPROLIFERATIVE NEOPLASMS:AN EXPERIENCE FROM A TERTIARY CENTER IN SAUDI ARABIA

EHA Library, Mousa Alhaddad, 4162210

RESULTS OF TARGET THERAPY IN PATIENTS WITH POLYCYTEMIA VERA

EHA Library, Maria Pankrashkina, 4162211

NEUTROPHIL-LYMPHOCYTE RATIO IN POLYCYTHAEMIA VERA: INSIGHTS FROM A SINGLE-CENTRE STUDY

EHA Library, Harberth Fernandez - Leyva, 4162212

IBRUTINIB FOR RELAPSED REFRACTORY CLASSIC HODGKIN LYMPHOMA: RESULTS FROM AN INVESTIGATOR-INITIATED PHASE II TRIAL

EHA Library, Dipenkumar Modi, 4162213

THE COMBINATION OF NIVOLUMAB - IFOSFAMIDE - CARBOPLATIN - ETOPOSIDE (NICE) AS SALVAGE AND MOBILIZING REGIMEN IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA

EHA Library, Athanasios Liaskas, 4162214

CD163 AS A PROGNOSTIC FACTOR IN NODULAR SCLEROSIS CLASSICAL HODGKIN LYMPHOMA AND ITS POTENTIAL CLINICAL APPLICATION

EHA Library, Maksim Minaev, 4162215

THE TREATMENT EVOLUTION OF CLASSIC HODGKIN LYMPHOMA OVER TWO DECADES IN CHINA: REAL-WORLD EXPERIENCES OF AN ACADEMIC CENTER

EHA Library, Huiying Zhu, 4162216

NUTRITIONAL STATUS AND PROGNOSIS IN HODGKIN LYMPHOMA: THE IMPACT OF THE CONUT SCORE

EHA Library, Didem KOCA, 4162217

HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN HODGKIN LYMPHOMA: A MULTICENTER REAL-WORLD ANALYSIS FROM TURKEY

EHA Library, Merve Ecem Erdoğan Yön, 4162218

EFFICACY OF NIVOLUMAB PLUS AVD IN PATIENTS WITH CLASSICAL HODGKIN'S LYMPHOMA (HL): A SINGLE-CENTER EXPERIENCE (PILOT STUDY)

EHA Library, Evgenii Kunevich, 4162219

HODGKIN'S LYMPHOMA: INFILTRATION OF THE CENTRAL NERVOUS SYSTEM.

EHA Library, Lucy Gonzalez, 4162220

NOVEL COMBINATION REGIMEN BRENTUXIMAB VEDOTIN-BEGE ACHIEVES REMARKABLE EFFICACY IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA

EHA Library, Xi Chen, 4162221

EMPEGFILGRASTIM SUPPORT FOR FULL-DOSE THERAPY OF 6-EACODD-14 PROGRAM FOR ADVANCED STAGES HODGKIN'S LYMPHOMA PATIENTS.

EHA Library, Vladislav Sarzhevskij, 4162222

CRP-ALBUMIN RATIO FOR PREDICTION OF INTERIM COMPLETE REMISSION AND PROGRESSION-FREE SURVIVAL IN HODGKIN LYMPHOMA

EHA Library, Tugcan Alp Kirkizlar, 4162223

EFFICACY AND SAFETY OF NIVOLUMAB IN COMBINATION WITH AVD IN PATIENTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA: A PROSPECTIVE SINGLE-CENTER CLINICAL TRIAL

EHA Library, Diana Ivanova, 4162224

EPIDEMIOLOGICAL CHARACTERISTICS OF HODGKIN'S LYMPHOMA IN BRAZIL: INCIDENCE AND GEOGRAPHIC DISTRIBUTION.

EHA Library, Gerson de Paula, 4162225

PERSONALIZED NIVOLUMAB-BASED DE-ESCALATED STRATEGY AS FRONTLINE THERAPY FOR HIGH-RISK PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA

EHA Library, Anna Kravtsova, 4162226

IMPACT OF OMISSION OF BLEOMYCIN ON LONG TERM SURVIVAL IN ADVANCED STAGE HODGKIN LYMPHOMA IMPACT OF OMISSION OF BLEOMYCIN ON LONG TERM SURVIVAL IN ADVANCED STAGE HODGKIN LYMPHOMA

EHA Library, Mohammad Al-Rwashdeh, 4162227

THE RELATIONSHIP BETWEEN PROGNOSTIC NUTRITIONAL INDEX AT THE TIME OF DIAGNOSIS AND PROGNOSIS IN PATIENTS WITH HODGKIN'S LYMPHOMA

EHA Library, Serife Solmaz, 4162228

CLASSICAL HODGKIN LYMPHOMA IN MOROCCO : A RETROSPECTIVE STUDY HIGHLIGHTING MANAGEMENT STRATEGIES AND SOCIO-ECONOMIC CHALLENGES

EHA Library, Yossra AGHOUTANE, 4162229

SMARTCYTOFLOW 2.0: INTEGRATING GENERATIVE AI FOR EXPLAINABLE AND ACTIONABLE FLOW CYTOMETRY ANALYSIS IN NON-HODGKIN LYMPHOMA DIAGNOSIS

EHA Library, Adrian Mosquera-Orgueira, 4162230

PRIMAVERA: A PHASE I/II STUDY TO EVALUATE SAFETY AND EFFICACY OF AZD3470, A PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) INHIBITOR, IN PARTICIPANTS WITH RELAPSED/REFRACTORY HEMATOLOGIC MALIGNANCIES

EHA Library, Enrico Derenzini, 4162231

REAL-WORLD USE OF BRENTUXIMAB VEDOTIN IN ADULT PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA: A RETROSPECTIVE ANALYSIS FROM A COLOMBIAN HEALTHCARE REGISTRY (2016-2023)

EHA Library, Leonardo Enciso-Olivera, 4162232

BRENTUXIMAB VEDOTIN AND CHECK POINT INHIBITORS COMBINATION THERAPY IN HEAVELY PRE-TREATED RELAPSED REFRACTORY HODGKIN'S LYMPHOMA: A SINGLE CENTRE RETROSPECTIVE ANALYSIS

EHA Library, Fatima Lamraoui, 4162233

EXPLORING THE IMMUNOGENETIC LINK BETWEEN YOUNG-ONSET HODGKIN LYMPHOMA AND MULTIPLE SCLEROSIS: A TWO-CASE REPORT ON DISEASE CO-OCCURRENCE

EHA Library, Elena Pîrvu, 4162234

BV-AVD 1ST LINE TREATMENT RETROSPECTIVE ANALYSIS, KUWAIT CANCER CENTER EXPERIENCE.

EHA Library, Rasha Abd El-Tawab Hamed, 4162235

EVALUATION OF FIRST-LINE TREATMENT WITH ABVD REGIMEN IN PATIENTS WITH ADVANCED STAGE HODGKIN LYMPHOMA (STAGE III-IV)

EHA Library, Karen Torres, 4162236

PEMBROLIZUMAB AS A THERAPEUTIC STRATEGY FOR HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS SECONDARY TO HODGKIN'S LYMPHOMA

EHA Library, Barbara Jezeršek Novaković, 4162237

REAL WORLD OUTCOMES OF PET-ADAPTED TREATMENT OF CLASSIC HODGKIN'S LYMPHOMA: A SINGLE TERTIARY CARE CENTER STUDY

EHA Library, IMRAN IFTIKHAR, 4162238

BRENTUXIMAB VEDOTIN USED IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA: AN EXPERIENCE FROM NORTH MACEDONIA

EHA Library, Slobodanka Trpkovska Terzieva, 4162239

HODGKIN'S LYMPHOMA IN A TUNISIAN HEMATOLOGY CENTER: CLINICAL AND THERAPEUTIC OUTCOMES UNDER A STANDARDIZED PROTOCOL

EHA Library, Kmar Mrad, 4162240

A CLINICAL CHALLENGE: PEMBROLIZUMAB-INDUCED CARDIOTOXICITY IN A TEENAGER WITH HODGKIN LYMPHOMA - CASE REPORT AND LITERATURE REVIEW

EHA Library, ichrak hajaj, 4162241

FAILURE OF FRONTLINE TREATMENT IN HODGKIN LYMPHOMA AND THE OUTCOMES OF SALVAGE THERAPY - 20 YEARS EXPERIENCE IN A SINGLE INSTITUTION

EHA Library, Tran-Der Tan, 4162242

REAL WORLD OUTCOMES OF PET-ADAPTED TREATMENT OF CLASSIC HODGKIN'S LYMPHOMA: A SINGLE TERTIARY CARE CENTRE STUDY

EHA Library, IMRAN IFTIKHAR, 4162243

LYMPHADENOPATHY IN SYSTEMIC LUPUS ERYTHEMATOSUS: CHARACTERISTICS AND DEVELOPMENT OF A PREDICTIVE RISK MODEL.

EHA Library, Blanca Sanchez-Gonzalez, 4162244

PET-ADAPTED APPROACHES TO PRIMARY THERAPY FOR CLASSICAL HODGKIN LYMPHOMA IN ARMENIA, A MIDDLE-INCOME COUNTRY.

EHA Library, Davit Melkonyan, 4162245

EPIDEMIOLOGICAL TRENDS AND PATTERNS OF HODGKIN LYMPHOMA AMONG SAUDI NATIONALS: A 10-YEAR RETROSPECTIVE ANALYSIS (2011-2020)

EHA Library, Abdulrahman Algarni, 4162246

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR RELAPSED OR REFRACTORY HODGKIN'S LYMPHOMA IN PEDIATRIC PATIENTS: A SINGLE-CENTER STUDY.

EHA Library, Roua Hsasna, 4162247

REFRACTORY AND/OR RELAPSED HODGKIN'S LYMPHOMA: A MONOCENTRIC EXPERIENCE OF THE HEMATOLOGY DEPARTMENT OF MONASTIR.

EHA Library, oumeyma touati, 4162248

PREVALENCE, RESPONSE TO TREATMENT AND OUTCOME OF LIMITED-STAGE FOLLICULAR LYMPHOMA: A SINGLE-CENTER RETROSPECTIVE STUDY.

EHA Library, Marco Carraro, 4162249

BRIDGING GAPS IN MANTLE CELL LYMPHOMA (MCL) MANAGEMENT: A GLOBAL COMPARISON OF BTK INHIBITOR USAGE AMONG EXPERTS AND HEALTHCARE PROFESSIONALS

EHA Library, Ryan Topping, 4162250

STUDY RESULTS ON TP53 GENE ALTERATIONS IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMAS INTRODUCTION

EHA Library, Liliya Gorenkova, 4162251

THE EFFECTS OF EARLY (POD 24) AND LATE PROGRESSION OVER THE DISEASE COURSE IN PATIENTS WITH FOLLICULAR LYMPHOMA.

EHA Library, Merve Yüksel, 4162252

BI-1206, AN ANTIBODY TARGETING FCγRIIB, GIVEN IN COMBINATION WITH RITUXIMAB AND ACALABRUTINIB IN SUBJECTS WITH INDOLENT B-CELL NON-HODGKIN'S LYMPHOMA

EHA Library, Laura Fogliatto, 4162253

MAINTENANCE WITH RITUXIMAB IN POST-INDUCTION MARGINAL ZONE LYMPHOMA: YES OR NO? OUR EXPERIENCE WITH LONG FOLLOW-UP.

EHA Library, MATTEO D'ADDONA, 4162254

ZANUBRUTINIB MAINTENANCE IN MCL POST-INDUCTION: A SINGLE-CENTER STUDY

EHA Library, jiaping wang, 4162255

POLATUZUMAB VEDOTIN AS AN EFFECTIVE SALVAGE THERAPY FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA RESISTANTANCE TO BTK AND BCL INHIBITORS

EHA Library, Ping Yang, 4162256

TREATMENT OUTCOME FOR GASTRIC MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA WITH HELICOBACTER PYLORI NEGATIVE

EHA Library, Sungnam Lim, 4162257

A PROSPECTIVE, TWO-ARM, PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORELABRUTINIB PLUS ZUBERITAMAB WITH OR WITHOUT LENALIDOMIDE (HILO) IN PATIENTS WITH TREATMENT-NAÏVE MARGINAL ZONE LYMPHOMA

EHA Library, He Li, 4162258

TITANIUM: AN OPEN-LABEL, MULTICENTER PHASE 1/2 STUDY OF AZD5492, A FIRST-IN-CLASS SUBCUTANEOUS CD8-GUIDED TRISPECIFIC T-CELL ENGAGER, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL MALIGNANCIES

EHA Library, Philip Thompson, 4162259

MOLECULAR GENETIC FEATURES OF MANTLE CELL LYMPHOMA

EHA Library, Nadezhda Nemscveridze, 4162260

EFFICACY OF SALVAGE THERAPY IN THE TREATMENT OF HELICOBACTER PYLORI-POSITIVE GASTRIC LOW-GRADE MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA

EHA Library, Sungnam Lim, 4162261

A CLINICAL CASE OF SUCCESSFUL USE OF IBRUTINIB IN RELAPSED MANTLE CELL LYMPHOMA (MCL) WITH CNS INVOLVEMENT AND RESULTS OF A META-ANALYSIS

EHA Library, Evgenii Kunevich, 4162262

GOLSEEK-4: A MULTICENTER PHASE 3 RANDOMIZED OPEN-LABEL STUDY COMPARING EFFICACY AND SAFETY OF GOLCADOMIDE + RITUXIMAB VS INVESTIGATOR'S CHOICE IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA

EHA Library, Eliza A. Hawkes, 4162263

IBRUTINIB IN MANTLE CELL LYMHOMA: A SINGLE CENTER EXPERIENCE IN TURKEY

EHA Library, Gülcan Kökcü, 4162264

THERAPY REFRACTORY ICANS AFTER CAR T CELL THERAPY WITH BREXUCABTAGENE-AUTOLEUCEL (TECARTUS) FOR RELAPSED MANTLE CELL LYMPHOMA: SUCCESSFUL MANAGEMENT WITH INTRATHECAL TRIPLE CHEMOTHERAPY

EHA Library, Maike Meier, 4162265

ZANUBRUTINIB REAL-WORLD ANALYSIS IN MARGINAL ZONE LYMPHOMA

EHA Library, Kim Linton, 4162266

REFINING TREATMENT PARADIGMS FOR MANTLE CELL LYMPHOMA: A TAILORED APPROACH

EHA Library, Won Seog Kim, 4162267

LENALIDOMIDE-INDUCED DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) COMPLICATED WITH MYOCARDITIS: A RARE BUT POTENTIALLY FATAL TOXICITY OF IMMUNOTHERAPY

EHA Library, Xiyang Liu, 4162268

CHOLLESTEROLL METABOLLIIC REPROGRAMMIING DRIIVES THE ONSET OF DLBCL AND REPRESENTS A PROMIISIING THERAPEUTIIC TARGET

EHA Library, Lili Zhou, 4162269

EFFICACY OF ZANUBRUTINIB PLUS R-CHOP VERSUS R-CHOP ALONE IN NEWLY DIAGNOSED INTRAVASCULAR LARGE B-CELL LYMPHOMA: A RETROSPECTIVE STUDY

EHA Library, Chao Chen, 4162270

REAL-WORLD STUDY OF GOLIDOCITINIB FOR THE TREATMENT OF RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA: RETROSPECTIVE DATA FROM MEDICAL CENTERS IN CHINA

EHA Library, Yan Gao, 4162271

A PROPOSED PROGNOSTIC SCORE INCLUDING CIRCULATING FREE DNA (CFDNA) CONCENTRATION IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL); SINGLE CENTRE STUDY

EHA Library, Esraa Jamal, 4162272

POLATUZUMAB VEDOTIN AND GLOFITAMAB IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: DATA FROM THE ITALIAN COMPASSIONATE USE PROGRAM

EHA Library, Giuseppe Gritti, 4162273

OUTCOME OF BURKITT LYMPHOMA IN REAL-WORLD SETTING: A MULTICENTER RETROSPECTIVE STUDY ON 104 CONSECUTIVE CASES DIAGNOSED AND TREATED IN KAZAKHSTAN OVER THE LAST DECADE

EHA Library, Saule Gabbassova, 4162274

AZACYTIDINE PLUS RITUXIMAB-GEMCITABINE-OXALIPLATIN AS SALVAGE TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Dongfeng Zeng, 4162275

PROGNOSTIC IMPACT OF NOTCH1/FBXW7/PHF6 MUTATIONS IN PEDIATRIC T-LYMPHOBLASTIC LYMPHOMA: A RUSSIAN MULTICENTER ANALYSIS

EHA Library, Volchkov Egor, 4162276

CAR-T TREATMENT STRATEGY FOR B-CELL LYMPHOMA: HIGH COMPLETE RESPONSE RATE IN M2 MACROPHAGES AND GRANULOCYTES DEFICIENCY IMMUE MICROENVIRONMENT

EHA Library, Danyang Li, 4162277

THE PROGNOSTIC ROLE OF EBV IN POST-TRANSPLANT- LYMPHOPROLIFERATIVE DISORDERS: A RETROSPECTIVE SINGLE CENTER STUDY

EHA Library, Periana Minga, 4162278

DURVALUMAB AND ACALABRUTINIB FOR RELAPSED/REFRACTORY (R/R) HIGH-GRADE B-CELL LYMPHOMA: MOST15, OPEN LABEL PHASE II SUB-STUDY OF THE MOLECULAR SCREENING AND THERAPEUTICS IN LEUKAEMIA AND LYMPHOMA FRAMEWORK

EHA Library, Steven Lane, 4162279

COMBINATION OF MITOXANTRONE HYDROCHLORIDE LIPOSOME WITH CHIDAMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T CELL LYMPHOMA: UPDATED RESULTS OF THE PHASE II STUDY

EHA Library, Zhi-Ming Li, 4162280

PITUITARY INVOLVEMENT IN DLBCL AND IVLBCL: A COMBINED FUNCTIONAL AND RADIOLOGICAL ANALYSIS

EHA Library, Hajime Sakuma, 4162281

ADJUSTING SERUM ß2-MICROGLOBULIN LEVELS (Sß2M) ACCORDING TO RENAL FUNCTION IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): IMPACT ON PROGNOSTIC SIGNIFICANCE

EHA Library, Theodoros Vassilakopoulos, 4162282

IMMUNE DYSREGULATION IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AND HIGH-GRADE B-CELL LYMPHOMA (HGBL) WITH MYC, BCL2, AND/OR BCL6 REARRANGEMENTS: A COMPARATIVE ANALYSIS OF R-CHOP VERSUS R-DA-EPOCH REGIMENS.

EHA Library, Macarena Castillo Godoy, 4162283

COMBINATION OF BASELINE CA125 AND EOT FDG-PET DYNAMICALLY STRATIFIES FAILURE RISK IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA TREATED WITH DA-EPOCH-R: A REAL-LIFE RETROSPECTIVE ANALYSIS.

EHA Library, Alberto Fresa, 4162284